Specialty Pharma Journal Specialty, Precision & Technology
The National Institutes of Health and 11 leading biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot. PACT will initially focus on efforts to identify, develop and validate robust biomarkers — standardized biological markers …
Tag Archives: National Institutes of Health
October, 2017
September, 2017
-
21 September
Sanofi and NIH Researchers Develop Three-in-One Antibodies to Treat HIV
CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire/ — In a landmark study published in the journal Science today, researchers produced genetically engineered antibodies with the highest activity and breadth of coverage yet seen against human immunodeficiency virus (HIV-1). Natural antibodies recognize a single target on a foreign protein. In this study, …
April, 2017
-
17 April
Rates of New Diagnosed Cases of Type 1 and 2 Diabetes on the Rise Among Children, Teens
Rates of new diagnosed cases of type 1 and type 2 diabetes are increasing among youth in the United States, according to a report, Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012, published today in the New England Journal of Medicine. In the United States, 29.1 …
March, 2017
-
24 March
Facial Recognition Software Helps Diagnose Rare Genetic Disease
Researchers with the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, and their collaborators, have successfully used facial recognition software to diagnose a rare, genetic disease in Africans, Asians and Latin Americans. The disease, 22q11.2 deletion syndrome, also known as DiGeorge syndrome and velocardiofacial syndrome, …
December, 2016
-
12 December
Kite Pharma Announces Publication of T-Cell Therapy Targeting Mutant KRAS in Cancer by the NCI in NEJM
SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc. (Nasdaq:KITE) announced today that characterizations of T cell receptor candidates which it has licensed under the Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH) have been published in the December 8, 2016 New England Journal of Medicine (NEJM). The …
August, 2016
-
8 August
Allscripts’ 2bPrecise Launches a Genomics and Precision Medicine Initiative at NIH
CHICAGO, Aug. 08, 2016 (GLOBE NEWSWIRE) — 2bPrecise LLC, a wholly owned subsidiary of Allscripts Healthcare Inc. (Allscripts) (NASDAQ:MDRX), has launched a strategic early adopter program at the National Institutes of Health (NIH), America’s leading Care Institution for clinical research and a long-time Allscripts Sunrise™ client. The program will focus …
July, 2016
-
29 July
NIH-Led Researchers Develop Software that could Facilitate Drug Development
A team of researchers led by a National Institutes of Health investigator, Teresa Przytycka, Ph.D., has developed a new software tool called AptaTRACE that could be an important advance for drug developers and other scientists who want to identify molecules that bind with high precision to targets of interest. “This …
February, 2016
-
26 February
Surescripts Supports White House to Advance Precision Medicine Initiative
ARLINGTON, Va.–(BUSINESS WIRE)–Today Surescripts, the nation’s leading health information network, announces its support of President Obama’s Precision Medicine Initiative (PMI). Surescripts will participate in the White House Precision Medicine Initiative Summit and pledge its support to provide Surescripts’ infrastructure and technology to help the Precision Medicine Initiative aggregate the medical …